HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RV 538 (PDMP)

noninactivating inhibitor of ceramide-UDPG glucosyltransferase; RN given for unspecified HCl; structure given in first source
Also Known As:
PDMP; 1-phenyl-2-decanoylamino-3-morpholino-1-propanol; 2-decanoylamino-3-morpholino-1-phenylpropanol; D-PDMP compound; D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol; DAMPP; RV 538, (R-(R*,R*))-isomer; RV-538; threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol
Networked: 190 relevant articles (11 outcomes, 36 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nomura, Shosaku: 15 articles (01/2019 - 02/2003)
2. Shouzu, Akira: 8 articles (01/2012 - 07/2004)
3. Iwasaka, Toshiji: 6 articles (11/2009 - 01/2004)
4. Simoni-Wastila, Linda: 5 articles (01/2022 - 01/2017)
5. Inokuchi, Jin-ichi: 5 articles (01/2016 - 02/2003)
6. Inami, Norihito: 5 articles (01/2012 - 02/2009)
7. Henry, Stephen G: 4 articles (12/2021 - 01/2019)
8. Basu, Manju: 4 articles (01/2018 - 01/2004)
9. Ma, Rui: 4 articles (01/2018 - 01/2004)
10. Omoto, Seitarou: 4 articles (01/2012 - 01/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Opioid-Related Disorders (Opiate Addiction)
3. Substance-Related Disorders (Drug Abuse)
4. Pain (Aches)
5. Atherosclerosis

Related Drugs and Biologics

1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2. RV 538 (PDMP)
3. Opioid Analgesics (Opioids)
4. Ceramides
5. Controlled Substances
6. Glycosphingolipids
7. Glucosylceramides (Glucocerebrosides)
8. G(M3) Ganglioside
9. CDw17 antigen (lactosylceramide)
10. Therapeutic Uses

Related Therapies and Procedures

1. Therapeutics
2. Postoperative Care
3. Tonsillectomy
4. Life Support Care
5. Renal Dialysis (Hemodialysis)